Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:52 PM UTC
| NCT Number | NCT07363577 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 456 participants |
| Active Locations | 13 sites in the US |
| Sponsor | LB Pharmaceuticals Inc. |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 27, 2026: Clinical trial NCT07363577 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 13 locations across the United States. The study is sponsored by LB Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07363577 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07363577 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.